|
![[Homepage]](../../../images/page_home.gif)
![[About SIGN]](../../../images/page_about.gif)
![[New]](../../../images/page_new.gif)
![[Guidelines]](../../../images/page_guide.gif)
![[Development Process]](../../../images/page_dev.gif) ![[Patients]](../../../images/page_patients.gif)
![[Events]](../../../images/page_events.gif)
![[Links]](../../../images/page_links.gif)
![[Search]](../../../images/page_search.gif)
|
Contents
The Guideline and Quick Reference Guide are available to download in Acrobat
pdf format (info). Quick
Reference Guide (280K) Guideline (1.5MB).
- Introduction
- Prevention, surveillance and genetics
- Diagnosis and prognostic indicators
- Surgical management and staging
- Further investigations and non-surgical staging
- Adjuvant treatment of stage II and III disease
- Patient follow up in stage I, II and III disease
- Management of stage IV disease
- Melanoma in women
- Information for patients
- Implementation and audit
- Development of the guideline
|
![[Guideline 42 Cover]](../../../images/g42.jpg)
|
![[Cutaneous melanoma SIGN Guideline 72]](../../../images/g72.jpg)
![[Bullet]](../../../images/14ptarrow.gif){kind=small}
![[Top]](../../../images/top.gif){kind=small}